|Acute Kidney Injury (AKI)|
|Acute Renal Failure|
|Chronic Kidney Disease (CKD)|
|Cardiovascular Disease (CVD)|
New findings could explain, at least in part, why live kidney donation has stagnated in the U.S.
Patients experience relief with the use of gabapentin and pregabalin.
Persistent need for dialysis at discharge increased the likelihood of readmission nearly threefold, study finds.
Plasma vitamin D levels increased to greater than 50 nmol/L in 80% of patients.
Recipients of kidneys from smokers are twice as likely to die as patients who get kidneys from nonsmokers.
Patients report dry mouth sensation and difficulties swallowing.
From 2004 to 2010, the median fall in eGFR in the first year after donation grew significantly from 23.3 to 31.9 mL/min/1.73 m2.
Delayed graft function in patients aged 70 and older increased their death risk twofold.
The annual per-patient cost for kidney transplant recipients dropped from $33,040 in 2007 to $18,746 in 2011.
Cytomegalovirus viremia less likely with 200 rather than 100 days of valganciclovir after kidney transplantation.
Significant associations seen in men's urinary and sexual function based on surgeon.
Dose and duration of opioid use associated with increased odds of erectile dysfunction.
Radium-223, a first-in-class drug, travels directly to the site of bone metastases, where it emits alpha particles that exert an anti-tumor effect.
Taiwan study finds a twofold increased risk of upper urinary tract stones in patients suffering from urinary incontinence.
Researchers studied 850 testosterone-deficient men who received 1,000 mg parenteral testosterone undecanoate six weeks after baseline and then every 12 weeks for up to five years.
Under-treatment persists despite heavy promotion in the media.
Routine screening for bladder cancer may be warranted in this patient population.
Compared with radical nephrectomy, nephron-sparing surgery shift serum creatinine downward.
Shared decision-making about screening recommended for men aged 55-69 years.
Highest intake was associated with a 46% decreased progression risk compared with the lowest intake.